SlideShare une entreprise Scribd logo
1  sur  26
 
=  f  (  )
Toxicity MW Series of CONGENERIES
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],f(x) regressions classification x1 x2
REACH   promotes Innovation   (  Article 1  )  All Info  should be used QSAR  is mentioned
TARGET   is   Environment / Man
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],  Seven Reasons to use QSAR
[object Object],[object Object],[object Object],[object Object],[object Object],QSAR can be used
[object Object],[object Object],[object Object],[object Object],[object Object],QSAR can be used
[object Object],[object Object],[object Object],QSAR can be used
PHYSICO-CHEMICAL PROPERTIES  have  low  experimental variability   and  many data CHRONIC HUMAN TOXICITY  has  high  variability  and  low number of data
On one side  we have the starting data for a certain  endpoint , at the basis of the model On the other side  we have a specific use
 

Contenu connexe

En vedette

Discovery Bus: UK QSAR meeting at GSK
Discovery Bus: UK QSAR meeting at GSKDiscovery Bus: UK QSAR meeting at GSK
Discovery Bus: UK QSAR meeting at GSKDavid Leahy
 
Automating Drug Design Nov 13th 2009 97
Automating Drug Design Nov 13th 2009 97Automating Drug Design Nov 13th 2009 97
Automating Drug Design Nov 13th 2009 97David Leahy
 
Introduction to OECD QSAR Toolbox
Introduction to OECD QSAR ToolboxIntroduction to OECD QSAR Toolbox
Introduction to OECD QSAR Toolboxguestcfca1eb1
 
Qsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar aloneQsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar alonesagar alone
 
QSAR Study on Antitubercular Drug Derivatives
QSAR Study on Antitubercular Drug DerivativesQSAR Study on Antitubercular Drug Derivatives
QSAR Study on Antitubercular Drug DerivativesLydia Yeshitla
 
Data Analysis in QSAR
Data Analysis in QSARData Analysis in QSAR
Data Analysis in QSARbaoilleach
 
Sagar alone qsar studies of saponin analogues for anticancer activity
Sagar alone  qsar studies of saponin analogues for anticancer activitySagar alone  qsar studies of saponin analogues for anticancer activity
Sagar alone qsar studies of saponin analogues for anticancer activitysagar alone
 
Effect of substituents and functions on drug structure activity relationships
Effect of substituents and functions on drug structure activity relationshipsEffect of substituents and functions on drug structure activity relationships
Effect of substituents and functions on drug structure activity relationshipsOmar Sokkar
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug designAli Ahsan
 
Computer Aided Drug Design QSAR Related Methods
Computer Aided Drug Design QSAR Related MethodsComputer Aided Drug Design QSAR Related Methods
Computer Aided Drug Design QSAR Related MethodsJahan B Ghasemi
 
Computational Drug Design
Computational Drug DesignComputational Drug Design
Computational Drug Designbaoilleach
 
Free wilson analysis qsar
Free wilson analysis qsarFree wilson analysis qsar
Free wilson analysis qsarRahul B S
 

En vedette (18)

Discovery Bus: UK QSAR meeting at GSK
Discovery Bus: UK QSAR meeting at GSKDiscovery Bus: UK QSAR meeting at GSK
Discovery Bus: UK QSAR meeting at GSK
 
Automating Drug Design Nov 13th 2009 97
Automating Drug Design Nov 13th 2009 97Automating Drug Design Nov 13th 2009 97
Automating Drug Design Nov 13th 2009 97
 
Introduction to OECD QSAR Toolbox
Introduction to OECD QSAR ToolboxIntroduction to OECD QSAR Toolbox
Introduction to OECD QSAR Toolbox
 
Qsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar aloneQsar studies of saponine analogues for anticancer activity by sagar alone
Qsar studies of saponine analogues for anticancer activity by sagar alone
 
QSAR Study on Antitubercular Drug Derivatives
QSAR Study on Antitubercular Drug DerivativesQSAR Study on Antitubercular Drug Derivatives
QSAR Study on Antitubercular Drug Derivatives
 
Data Analysis in QSAR
Data Analysis in QSARData Analysis in QSAR
Data Analysis in QSAR
 
Sagar alone qsar studies of saponin analogues for anticancer activity
Sagar alone  qsar studies of saponin analogues for anticancer activitySagar alone  qsar studies of saponin analogues for anticancer activity
Sagar alone qsar studies of saponin analogues for anticancer activity
 
25.qsar
25.qsar25.qsar
25.qsar
 
Effect of substituents and functions on drug structure activity relationships
Effect of substituents and functions on drug structure activity relationshipsEffect of substituents and functions on drug structure activity relationships
Effect of substituents and functions on drug structure activity relationships
 
Computer aided drug design
Computer aided drug designComputer aided drug design
Computer aided drug design
 
Computer Aided Drug Design QSAR Related Methods
Computer Aided Drug Design QSAR Related MethodsComputer Aided Drug Design QSAR Related Methods
Computer Aided Drug Design QSAR Related Methods
 
Meta QSAR
Meta QSARMeta QSAR
Meta QSAR
 
Computer Aided Drug Design
Computer Aided Drug DesignComputer Aided Drug Design
Computer Aided Drug Design
 
Qsar lecture
Qsar lectureQsar lecture
Qsar lecture
 
QSAR
QSARQSAR
QSAR
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
 
Computational Drug Design
Computational Drug DesignComputational Drug Design
Computational Drug Design
 
Free wilson analysis qsar
Free wilson analysis qsarFree wilson analysis qsar
Free wilson analysis qsar
 

Similaire à Qsar introduction beginners

Multi-omics infrastructure and data for R/Bioconductor
Multi-omics infrastructure and data for R/BioconductorMulti-omics infrastructure and data for R/Bioconductor
Multi-omics infrastructure and data for R/BioconductorLevi Waldron
 
CAMERA Presentation at KNAW ICoMM Colloquium May 2008
CAMERA Presentation at KNAW ICoMM Colloquium May 2008CAMERA Presentation at KNAW ICoMM Colloquium May 2008
CAMERA Presentation at KNAW ICoMM Colloquium May 2008Saul Kravitz
 
Module 5 - EN - Promoting data use III: Most frequent data analysis techniques
Module 5 - EN - Promoting data use III: Most frequent data analysis techniques Module 5 - EN - Promoting data use III: Most frequent data analysis techniques
Module 5 - EN - Promoting data use III: Most frequent data analysis techniques Alberto González-Talaván
 
Paper presentation @DILS'07
Paper presentation @DILS'07Paper presentation @DILS'07
Paper presentation @DILS'07Paolo Missier
 
Building bioinformatics resources for the global community
Building bioinformatics resources for the global communityBuilding bioinformatics resources for the global community
Building bioinformatics resources for the global communityExternalEvents
 
Jax bio dataworldcongress.ngs.20181128finalwithoutbu
Jax bio dataworldcongress.ngs.20181128finalwithoutbuJax bio dataworldcongress.ngs.20181128finalwithoutbu
Jax bio dataworldcongress.ngs.20181128finalwithoutbuAnne Deslattes Mays
 
2014 Taverna Tutorial Introduction to eScience and workflows
2014 Taverna Tutorial Introduction to eScience and workflows2014 Taverna Tutorial Introduction to eScience and workflows
2014 Taverna Tutorial Introduction to eScience and workflowsmyGrid team
 
NCI Cancer Genomic Data Commons for NCAB September 2016
NCI Cancer Genomic Data Commons for NCAB September 2016NCI Cancer Genomic Data Commons for NCAB September 2016
NCI Cancer Genomic Data Commons for NCAB September 2016Warren Kibbe
 
Quantitative Medicine Feb 2009
Quantitative Medicine Feb 2009Quantitative Medicine Feb 2009
Quantitative Medicine Feb 2009Ian Foster
 
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA
20160219 - S. De Toffol -  Dal Sanger al NGS nello studio delle mutazioni BRCA �20160219 - S. De Toffol -  Dal Sanger al NGS nello studio delle mutazioni BRCA �
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA Roberto Scarafia
 
HPC, Machine Learning, and Big Data
HPC, Machine Learning, and Big DataHPC, Machine Learning, and Big Data
HPC, Machine Learning, and Big DataWarren Kibbe
 
GeoComputation Conference - Dallas (2015)
GeoComputation Conference - Dallas (2015)GeoComputation Conference - Dallas (2015)
GeoComputation Conference - Dallas (2015)Irene Garcia-Marti
 
Integrative Networks Centric Bioinformatics
Integrative Networks Centric BioinformaticsIntegrative Networks Centric Bioinformatics
Integrative Networks Centric BioinformaticsNatalio Krasnogor
 
Near Infrared Surface Enhanced Raman Spectroscopy Ceh 11 3 2010
Near Infrared Surface Enhanced Raman Spectroscopy Ceh 11 3 2010Near Infrared Surface Enhanced Raman Spectroscopy Ceh 11 3 2010
Near Infrared Surface Enhanced Raman Spectroscopy Ceh 11 3 2010Chaz874
 
Bioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysisBioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysisDespoina Kalfakakou
 

Similaire à Qsar introduction beginners (20)

Multi-omics infrastructure and data for R/Bioconductor
Multi-omics infrastructure and data for R/BioconductorMulti-omics infrastructure and data for R/Bioconductor
Multi-omics infrastructure and data for R/Bioconductor
 
Ngs part i 2013
Ngs part i 2013Ngs part i 2013
Ngs part i 2013
 
CAMERA Presentation at KNAW ICoMM Colloquium May 2008
CAMERA Presentation at KNAW ICoMM Colloquium May 2008CAMERA Presentation at KNAW ICoMM Colloquium May 2008
CAMERA Presentation at KNAW ICoMM Colloquium May 2008
 
BioData World Basel 2018
BioData World Basel 2018BioData World Basel 2018
BioData World Basel 2018
 
Module 5 - EN - Promoting data use III: Most frequent data analysis techniques
Module 5 - EN - Promoting data use III: Most frequent data analysis techniques Module 5 - EN - Promoting data use III: Most frequent data analysis techniques
Module 5 - EN - Promoting data use III: Most frequent data analysis techniques
 
Paper presentation @DILS'07
Paper presentation @DILS'07Paper presentation @DILS'07
Paper presentation @DILS'07
 
Building bioinformatics resources for the global community
Building bioinformatics resources for the global communityBuilding bioinformatics resources for the global community
Building bioinformatics resources for the global community
 
Jax bio dataworldcongress.ngs.20181128finalwithoutbu
Jax bio dataworldcongress.ngs.20181128finalwithoutbuJax bio dataworldcongress.ngs.20181128finalwithoutbu
Jax bio dataworldcongress.ngs.20181128finalwithoutbu
 
2014 Taverna Tutorial Introduction to eScience and workflows
2014 Taverna Tutorial Introduction to eScience and workflows2014 Taverna Tutorial Introduction to eScience and workflows
2014 Taverna Tutorial Introduction to eScience and workflows
 
New tools for field grains surveillance
New tools for field grains surveillanceNew tools for field grains surveillance
New tools for field grains surveillance
 
NCI Cancer Genomic Data Commons for NCAB September 2016
NCI Cancer Genomic Data Commons for NCAB September 2016NCI Cancer Genomic Data Commons for NCAB September 2016
NCI Cancer Genomic Data Commons for NCAB September 2016
 
Quantitative Medicine Feb 2009
Quantitative Medicine Feb 2009Quantitative Medicine Feb 2009
Quantitative Medicine Feb 2009
 
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA
20160219 - S. De Toffol -  Dal Sanger al NGS nello studio delle mutazioni BRCA �20160219 - S. De Toffol -  Dal Sanger al NGS nello studio delle mutazioni BRCA �
20160219 - S. De Toffol - Dal Sanger al NGS nello studio delle mutazioni BRCA
 
HPC, Machine Learning, and Big Data
HPC, Machine Learning, and Big DataHPC, Machine Learning, and Big Data
HPC, Machine Learning, and Big Data
 
Ngs part ii 2013
Ngs part ii 2013Ngs part ii 2013
Ngs part ii 2013
 
GeoComputation Conference - Dallas (2015)
GeoComputation Conference - Dallas (2015)GeoComputation Conference - Dallas (2015)
GeoComputation Conference - Dallas (2015)
 
Integrative Networks Centric Bioinformatics
Integrative Networks Centric BioinformaticsIntegrative Networks Centric Bioinformatics
Integrative Networks Centric Bioinformatics
 
Near Infrared Surface Enhanced Raman Spectroscopy Ceh 11 3 2010
Near Infrared Surface Enhanced Raman Spectroscopy Ceh 11 3 2010Near Infrared Surface Enhanced Raman Spectroscopy Ceh 11 3 2010
Near Infrared Surface Enhanced Raman Spectroscopy Ceh 11 3 2010
 
K1 K. Straif
K1 K. StraifK1 K. Straif
K1 K. Straif
 
Bioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysisBioinformatics tools for NGS data analysis
Bioinformatics tools for NGS data analysis
 

Dernier

The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024Rafal Los
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024The Digital Insurer
 
Tech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfTech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfhans926745
 
Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slidevu2urc
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationMichael W. Hawkins
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...DianaGray10
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationSafe Software
 
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...Neo4j
 
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024The Digital Insurer
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CVKhem
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)Gabriella Davis
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilV3cube
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...apidays
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Scriptwesley chun
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdflior mazor
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfsudhanshuwaghmare1
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...apidays
 
Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024The Digital Insurer
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)wesley chun
 

Dernier (20)

The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024
 
Tech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfTech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdf
 
Histor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slideHistor y of HAM Radio presentation slide
Histor y of HAM Radio presentation slide
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day Presentation
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
 
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)
 
Developing An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of BrazilDeveloping An App To Navigate The Roads of Brazil
Developing An App To Navigate The Roads of Brazil
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
 
Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 

Qsar introduction beginners

  • 1.  
  • 2. = f ( )
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. Toxicity MW Series of CONGENERIES
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14. REACH promotes Innovation ( Article 1 ) All Info should be used QSAR is mentioned
  • 15. TARGET is Environment / Man
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. PHYSICO-CHEMICAL PROPERTIES have low experimental variability and many data CHRONIC HUMAN TOXICITY has high variability and low number of data
  • 22. On one side we have the starting data for a certain endpoint , at the basis of the model On the other side we have a specific use
  • 23.
  • 24.
  • 25.
  • 26.  

Notes de l'éditeur

  1. A BASIC INTRODUCTION TO QSAR
  2. The methods called quantitative structure-activity relationship (QSAR) are based on the assumption that the activity of a certain chemical compound is related to its structure. More precisely, this approach says that the activity, or the property, for instance the toxic effect, is related to the chemical structure through a certain mathematical algorithm, or rule. QSAR models are also called in silico methods, which actually refer to a somehow broader set of methods.
  3. These methods are real scientific methods and not science fiction.
  4. There is nothing magic about these methods.
  5. The basic assumption can be illustrated with this example. Let’s consider these pumpkins. We can distinguish them on the basis of their size, or shape, or weight. It means that we take into consideration some general characteristics of the pumpkins (photograph courtesy of G. Gini).
  6. Let’s consider this particular pumpkin. In this case, what makes this pumpkin different from another one is some particular parts of the pumpkin, that makes this an Hallowing pumpkin (photograph courtesy of G. Gini).
  7. In the case of chemical compounds the ways to consider their structure for the QSAR models is similar to that seen for the pumpkins: we can consider the presence of a particular characteristic in the chemical compound, which is present or not in the structure. For instance, it is well known that if in the chemical compound there are certain groups, like an aromatic amine, or an epoxide, there is a higher probability that the chemical compound is genotoxic. In this figure, Ashby draw an hypothetical chemical compound with a series of fragments related to higher genotoxic effect.
  8. In other cases, it is well know that toxic effect of chemical within a series of very similar compounds varies in a linear way. For instance, the toxic effect of the chemicals in the figure increases with the molecular weight (MW).
  9. The typical way to derive QSAR model is here represented. The basic assumption is that there is a mathematical function of the chemical properties which is related to the effect. Thus, the effect called y is a function called f of the chemical properties, called x. Mathematically, y = f(x). But how to find this mathematical algorithm f(x)? Typically, we use a number of chemical compounds with know values of the toxic effect (y). For each chemical compound we calculate a series of parameters, called chemical descriptors. Then, we find an algorithm that provides a quite accurate value, similar to the real experimental value. The final step is to check if the so-obtained algorithm is capable to predict the property values for other chemicals, not used to build up the model. This last phase is called validation of the QSAR model. This last phase is very important. Indeed, it is very important to generate a model which is working not only for the chemical substances used within the training set, but also for other chemicals. The challenge is to define the correct statistical properties of the model.
  10. There are many chemical descriptors, and we can calculate thousands of them. Here we list some of the major families of the chemical descriptors.
  11. Also for the algorithms we can use many different kinds of mathematical tools. We only mention that some models serve to split the compounds in classes, for instance toxic or not toxic, while other methods serve to calculate a continuous value, such as the toxic dose of a chemical (regression methods).
  12. In the USA there is a long tradition on the use of QSAR models, since the authorities have to evaluate the chemical substances within a relatively short period of time
  13. In the USA the use of QSAR models as support to the evaluation of the chemical properties is quite common.
  14. In Europe the recent REACH legislation gave new emphasis on the possible use of QSAR models to characterize the properties of chemical substances. REACH is the legislation that regulate the market of chemical substances, produced and imported. All chemical substances require characterization of their environmental and toxicological properties, before their use in Europe. This is a huge effort which requires chemical industry to notify the properties of their chemicals. REACH, since its first article, promotes innovation, and mentions that new, alternative methods should be searched to improve the evaluation of the chemicals. QSAR methods are included in the alternative methods.
  15. REACH wants to protect the human beings and the environment. The reason why innovation is mentioned, is that regulators are aware that existing methods to evaluate the effects on health and environment are mainly in vivo (animal) methods. However, the current methods are not sufficient to get appropriate knowledge on effects on human beings and environment. Alternative methods, including in silico models, and QSAR, may aim to mimic the in vivo methods, but may also be used to cover the knowledge gap which today exist.
  16. Sometimes it is said that QSAR models represent a way for industry to spend less for toxicological research, or can be used to save animals to be used for experiments. It is also added that the real target of REACH is the protection of health and environment, and for this purpose other methods are more reliable. Actually this position is in disagreement with what indicated by REACH. As we have seen, innovation is a milestone for REACH, and REACH states to use all pieces of information, in order to get a more reliable evaluation. The real challenge is not to indentify the best method to protect human beings and environment. The challenge is to take advantage of all the contributions that each approach, in vivo, in vitro, and in silico, offer. For this reason it is important to understand the multiple advantages offered by QSAR models. There at least seven reasons to use QSAR. 1. Innovation. We already discussed this. Very soon a huge amount of data, on 100,000 chemicals, will become available, through USA initiatives, like Tox21 and ToxCast. To analyse manually such a huge amount of data is obviously impossible, and thus computer, in silico methods, will represent a privileged way to explore these new values. 2. The time necessary for the experiments, in particular for the chronic endpoints, would be very long. QSAR methods are very fast. 3. The number of laboratory in Europe to make all the necessary studies may be insufficient. For instance, a recent evaluation done within ANTARES identified this lack of suitable laboratories in Italy. 4. The cost to perform all in vivo experiments would be very high, billions of euros. QSAR methods are often free. 5. Millions of animals should be used to get the necessary data. This raises ethical issues. 6. The regulators have to identify the most risky compounds, and check the dossier submitted by industries. Many tens of thousands of chemicals will be submitted to ECHA, the Agency responsible for the registration process. However, only a limited number of dossiers will be evaluated by regulators, about 5%. It means that the toxicity properties submitted by industries will not be checked for 19 substances, out of 20 chemicals registered. QSAR methods may offer tools to screen all registered chemicals, and identify in this way the chemicals which are predicted more toxic. 7. So far chemical industry addressed the development of new chemicals only on the basis of the target properties for the candidate new products. Critical issues, such as toxicity, have been analysed in a second stage, to comply to regulations. QSAR methods offer tools to incorporate the process of the evaluation of the toxic properties since the beginning of the planning of new compounds, within a pro-active strategy, minimizing the impact of chemicals on the environment and human beings, and reducing the economic resources due to the development of chemicals without the knowledge on their toxicological and environmental properties.
  17. There are several purposes to use QSAR for REACH. Results of QSAR models can be used to get data for the dossier for registration of the chemical substance, or for classification and labeling of the substance, or to prioritize the chemicals submitted according to their risk, as we discussed above. For these different purposes different QSAR methods can be used, and different requirements apply, on the needed reliability. Indeed, to prioritize chemicals we can use models even if we are 100% sure of their reliability, because the risky chemicals will be evaluated later on using other methods. Conversely, if the value obtained by the QSAR method has to be used to characterize the properties of the chemical substance for the dossier on that substance, much more reliable values should be used.
  18. Thus, QSAR models can be quite easily used for prioritization.
  19. More requirements exist in case of use of QSAR models for classification and labeling. However, we have to consider that industry may simply state that no data is available for a certain property. Thus, the value obtained by a QSAR model, even if with some uncertainty in its reliability, in most cases represent a better guess than no guess at all.
  20. As we said, to prepare the dossier with the requested data, the quality of the values has to be good. In this case we can consider the QSAR value as the single source of data, or as additional source of data. We agree that QSAR models are not reliable as unique source of data in many cases. We believe that in some cases, under defined conditions, values from QSAR models can be used as single source. In any case, we also think that values from QSAR models represent a valid source of additional data in many more cases.
  21. The reliability of the QSAR models strongly depends on the property. In case of physico-chemical properties, mainly in cases where there are thousands of data, good models exist. For this kind of endpoint, the uncertainty of the experimental data is limited. In case of more complex endpoints, and in particular for chronic endpoints for human toxicity, the number of data is more limited, and the uncertainty of the experimental values is much higher.
  22. Thus, the reliability of a QSAR model depends on the purpose we want to use it (for dossier preparation, for classification and labeling, or for prioritization) and on the data we use for the model. The QSAR model is like a bridge: we want to start from one side, with some data, and we want to reach the other side, which is not unique, but depends on the purpose, as we said.
  23. Certain QSAR models are quite risky, and only experts may use them, like some risky bridges.
  24. For some quite standardized, simple QSAR models, the reliability is quite high.
  25. The target of ANTARES is to evaluate the basis of the QSAR models, and identify a number of reliable QSAR models.